On October 12th 2011, Macopharma became aware of an official press release by Afssaps (French Drug and Medical Device Regulatory Body) regarding the (suite…)

Macopharma SA (« Macopharma ») is proud to announce that the Blood Centre of the German Red Cross NSTOB, Springe has chosen to implement the THERAFLEX MB-Plasma Pathogen Reduction System in routine use, to improve the safety of their Fresh Frozen Plasma (FFP).The centre plans to (suite…)

Macopharma SA (“Macopharma”), an innovator in global healthcare and provider of transfusion, infusion and cellular therapy products and solutions, is proud to announce that the Military Blood Center in Poland has chosen the THERAFLEX MB-Plasma Pathogen Reduction System as the exclusive (suite…)